Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Galli

Showing results (71-80 of 217) with videos related to

Pageof 22
Sort By:
The Journal of Antimicrobial Chemotherapy|September 7, 2005
Higher plasma lopinavir concentrations are associated with a moderate rise in cholestasis markers in HIV-infected patientsElena Seminari, Gianluca Gentilini, Laura Galli, et al.
The New Microbiologica|March 3, 2018
Potential associations between atazanavir exposure and clinical outcome: a pharmacokinetic sub-study from the MODAt randomized trialElisa Colella, Dario Cattaneo, Laura Galli, et al.
The Journal of Antimicrobial Chemotherapy|October 28, 2017
Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virusAntonella Castagna, Micol Ferrara, Laura Galli, et al.
Plos One|February 3, 2022
Risk of HIV viral rebound in HIV infected patients on direct acting antivirals (DAAs) treatment for HCVGiulia Morsica, Laura Galli, Emanuela Messina, et al.
Plos One|March 15, 2022
Association between low levels of HIV-1 DNA and HLA class I molecules in chronic HIV-1 infectionCamilla Muccini, Monica Guffanti, Vincenzo Spagnuolo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 14, 2019
Brief Report: Outcome of Acute Hepatitis B Virus Infection in HIV-1-Infected Patients: Possible Factors Associated With Resolution or ChronicityGiulia Morsica, Laura Galli, Simona Bossolasco, et al.
Journal of Oncology|February 21, 2022
Levels of Alpha-Fetoprotein and Association with Mortality in Hepatocellular Carcinoma of HIV-1-Infected PatientsGiulia Morsica, Laura Galli, Emanuela Messina, et al.
Frontiers in Medicine|October 4, 2023
Increasing incidence and prevalence of metabolic syndrome in people living with HIV during the COVID-19 pandemicRebecka Papaioannu Borjesson, Laura Galli, Camilla Muccini, et al.
The Journal of Infection|April 28, 2022
Proctitis and prostatitis by Neisseria meningitidis among MSM: A case seriesElena Bruzzesi, Angelo Roberto Raccagni, Diana Canetti, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 6, 2019
A liquid chromatography-tandem mass spectrometry method for simultaneous determination of simeprevir, daclatasvir, sofosbuvir, and GS-331007 applied to a retrospective clinical pharmacological studyDavide Ferrari, Sabrina Bagaglio, Michele Raso, et al.
Pageof 22

Showing results (71-80 of 217) with videos related to

Sort By:
Pageof 22
The Journal of Antimicrobial Chemotherapy|September 7, 2005
Higher plasma lopinavir concentrations are associated with a moderate rise in cholestasis markers in HIV-infected patientsElena Seminari, Gianluca Gentilini, Laura Galli, et al.
The New Microbiologica|March 3, 2018
Potential associations between atazanavir exposure and clinical outcome: a pharmacokinetic sub-study from the MODAt randomized trialElisa Colella, Dario Cattaneo, Laura Galli, et al.
The Journal of Antimicrobial Chemotherapy|October 28, 2017
Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virusAntonella Castagna, Micol Ferrara, Laura Galli, et al.
Plos One|February 3, 2022
Risk of HIV viral rebound in HIV infected patients on direct acting antivirals (DAAs) treatment for HCVGiulia Morsica, Laura Galli, Emanuela Messina, et al.
Plos One|March 15, 2022
Association between low levels of HIV-1 DNA and HLA class I molecules in chronic HIV-1 infectionCamilla Muccini, Monica Guffanti, Vincenzo Spagnuolo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 14, 2019
Brief Report: Outcome of Acute Hepatitis B Virus Infection in HIV-1-Infected Patients: Possible Factors Associated With Resolution or ChronicityGiulia Morsica, Laura Galli, Simona Bossolasco, et al.
Journal of Oncology|February 21, 2022
Levels of Alpha-Fetoprotein and Association with Mortality in Hepatocellular Carcinoma of HIV-1-Infected PatientsGiulia Morsica, Laura Galli, Emanuela Messina, et al.
Frontiers in Medicine|October 4, 2023
Increasing incidence and prevalence of metabolic syndrome in people living with HIV during the COVID-19 pandemicRebecka Papaioannu Borjesson, Laura Galli, Camilla Muccini, et al.
The Journal of Infection|April 28, 2022
Proctitis and prostatitis by Neisseria meningitidis among MSM: A case seriesElena Bruzzesi, Angelo Roberto Raccagni, Diana Canetti, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 6, 2019
A liquid chromatography-tandem mass spectrometry method for simultaneous determination of simeprevir, daclatasvir, sofosbuvir, and GS-331007 applied to a retrospective clinical pharmacological studyDavide Ferrari, Sabrina Bagaglio, Michele Raso, et al.
Pageof 22